Conclusion. Ceftobiprole is a novel, broad-spectrum, parenteral cephalosporin undergoing Phase III clinical trials. Its broad spectrum of activity makes it a candidate for monotherapy of cSSSIs ...
Phage therapy is the therapeutic use of bacteriophages to treat bacterial infections. It offers a precise, natural alternative to antibiotics using viruses that specifically target and kill bacteria ...
La Roche-Posay Pharmaceutical Laboratories, Asnières, France. Leaders Clinic, Seoul, Korea. [1] M. Jimbow and K. Jimbow, “Pigmentary Disorders in Oriental Skin ...
Christine M. Slover, PharmD, Infectious Diseases Fellow, Keith A. Rodvold, PharmD and Larry H. Danziger, PharmD, Professor, Department of Pharmacy Practice ...